Metoprolol Succinate Tablet, Extended Release
Product Images NDC 51407-404

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51407-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 403 10lb

Label for Metoprolol Succinate extended-release tablets, USP, 25 mg strength. The label indicates a bottle containing 1,000 tablets, marketed by Golden State Medical Supply, Inc. It includes storage instructions and a barcode. The product is prescription-only (Rx only).*

FDA Label Image

51407-404-01lb.jpg (51407 404 01lb)

Packaging label for Metoprolol Succinate extended-release tablets, USP, 50 mg strength, 100 count. The label shows the NDC number 51407-404-01 and indicates the product is for prescription use only (Rx only). It includes storage instructions and a barcode, with the labeler identified as GSMS Incorporated.*

FDA Label Image

51407-405-01lb.jpg (51407 405 01lb)

Label for Metoprolol Succinate extended-release tablets, USP, 100 mg strength from Golden State Medical Supply, Inc. The label indicates a bottle containing 100 tablets and includes storage instructions and a barcode. The NDC number 51407-405-01 is displayed. Warnings note the product contains metoprolol tartrate and should be kept out of reach of children.*

FDA Label Image

51407 406 10lb

Metoprolol Succinate extended-release tablets, USP, 200 mg strength, supplied in a 1,000 tablet bottle by Golden State Medical Supply, Inc. The label includes the NDC 51407-406-10, storage instructions at controlled room temperature, and a note indicating prescription-only status.*

FDA Label Image

Image-01 (Image 01)

Chemical structure of Metoprolol succinate, showing its molecular components and arrangement, including the aromatic ring, side chains, and succinate moiety.*

FDA Label Image

Image-02 (Image 02)

A forest plot chart titled "Results for Subgroups in MERIT-HF" displaying relative risk and 95% confidence intervals for metoprolol succinate extended-release tablets versus placebo. The chart includes three panels comparing total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure across various subgroups such as region, NYHA class, ejection fraction, etiology, sex, race, myocardial infarction history, diabetes, hypertension status, and heart rate.*

FDA Label Image

Image-03 (Image 03)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.